Related Experiment Video
Updated: Jan 31, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Efficacy of orthostatic self-training in medically refractory neurocardiogenic syncope
Haruhiko Abe1, Kiyotaka Kohshi, Yasuhide Nakashima
1The Second Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, Japan. haru-abe@med.uoeh-u.ac.jp
Background:
Orthostatic self-training is effective in the prevention of neurocardiogenic syncope, though the success of this method in drug refractory patients has not been reported. STUDY OBJECTIVE AND METHODS: This study examined the effectiveness of orthostatic self-training in 15 patients with head-up tilt testing (HUT)-inducible neurocardiogenic syncope, who were intolerant of, or refractory to standard drug therapy. They were enrolled in a home orthostatic self-training program for up to 30 min/session, twice daily. Head-up tilt testing was repeated within 4 weeks after onset of the training program, using the same protocol as at baseline. Orthostatic self-training was continued once daily, for up to 30 min, for a mean follow-up period of 11 months, in the drug-free state.
Results:
Syncope was not reinducible by follow-up HUT, and spontaneous syncope occurred in no patient during the follow-up period.
Conclusions:
Home orthostatic self-training, up to 30 min once daily following an initial twice daily program, was highly effective in the suppression of recurrent neurocardiogenic syncope in patients intolerant of, or refractory to standard drug therapy.
More Related Videos
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
14:09Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Related Concept Videos
Self-Efficacy
Heart Failure V: Medical Management
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Pericarditis III: Medical Management
Inhaled Medications